Literature DB >> 7524872

Are the days of transurethral resection of prostate for benign prostatic hyperplasia numbered? Urologists must grasp the future.

R S Kirby1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7524872      PMCID： PMC2540811          DOI： 10.1136/bmj.309.6956.716

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.

Authors:  R S Kirby; S W Coppinger; M O Corcoran; C R Chapple; M Flannigan; E J Milroy
Journal:  Br J Urol       Date:  1987-08

2.  Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy.

Authors:  J E Wennberg; N Roos; L Sola; A Schori; R Jaffe
Journal:  JAMA       Date:  1987-02-20       Impact factor: 56.272

3.  Outcome of elective prostatectomy.

Authors:  D E Neal; P D Ramsden; L Sharples; A Smith; P H Powell; R A Styles; R J Webb
Journal:  BMJ       Date:  1989-09-23

4.  Long-term urodynamic effects of finasteride in benign prostatic hyperplasia: a pilot study.

Authors:  R S Kirby; J Vale; J Bryan; K Holmes; J A Webb
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

5.  The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

Authors:  G J Gormley; E Stoner; R C Bruskewitz; J Imperato-McGinley; P C Walsh; J D McConnell; G L Andriole; J Geller; B R Bracken; J S Tenover
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

6.  Visual laser ablation of the prostate: clinical experience in 108 patients.

Authors:  J P Norris; D M Norris; R D Lee; M A Rubenstein
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

7.  Combination therapy for staghorn calculi in solitary kidneys: functional results with long-term followup.

Authors:  S B Streem; M A Geisinger
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

8.  A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.

Authors:  H Lepor; S Auerbach; A Puras-Baez; P Narayan; M Soloway; F Lowe; T Moon; G Leifer; P Madsen
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450
  8 in total
  2 in total

1.  New treatments for benign prostatic hypertrophy.

Authors:  M McKee; N Black; D Hunter; C Sanderson
Journal:  BMJ       Date:  1994-11-05

Review 2.  Managing lower urinary tract symptoms in older men.

Authors:  P Abrams
Journal:  BMJ       Date:  1995-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.